KEY TAKEAWAYS
- The trial aimed to compare team-based and technology-based SCC approaches in improving HrQOL in cancer pts.
- The primary outcome was a change in HrQOL. Secondary outcomes were changes in patient activation, satisfaction, and healthcare use.
- This study is underway to find the best way to deliver SCC and to improve SCC across different types of clinics in the United States.
Many cancer patients(pts) experience discordance between their care preferences and the care they receive. Team-based and technology-based approaches to supportive cancer care (SCC) can help address these problems, but it is unclear which approach is better.
Researchers aimed to compare team- and technology-based SCC approaches in improving cancer patients’ health-related quality of life (HrQOL).
The study enrolled 2,996 pts from 24 clinics (12 randomized into each group) in the United States. This included integrated community clinics, academic centers, Kaiser, VA, and safety-net centers. Eligible pts are those aged 21 or older, newly diagnosed with cancer, and English or Spanish speakers. Exclusions apply to those unable to provide consent, already enrolled in competing trials, or planning to relocate within 12 months. The primary outcome is the change in HrQOL using the Functional Assessment of Cancer Therapy-General survey, comparing baseline to 3 months post-enrollment. Secondary outcomes include changes in patient activation, satisfaction, and healthcare utilization (emergency department visits, hospitalizations, chemotherapy, radiation, surgery, palliative care, and hospice use) from baseline to 3, 6, and 12 months post-enrollment.
About 24 clinics have been approved to participate in the study. Of these clinics, 11 have screened a total of 1,075 pts and enrolled 165 participants. The majority of participants are male (77%), have less than a college degree (53.9%), and have an annual household income of $49,999 or less (27.3%).
This study is underway to find the best way to deliver SCC and to improve SCC across different types of clinics in the United States.
Source: https://ascopubs.org/doi/abs/10.1200/JCO.2023.41.16_suppl.e13617
Clinical Trial: https://www.clinicaltrials.gov/study/NCT05297734
Hector S. Medrano, Emily H. Wood, Kris Kapphahn, Madhuri Agarwal, Cynthia C. Perez, Marika Matthew, Keely E. Fuller, and Manali I. Patel. DOI: 10.1200/JCO.2023.41.16_suppl.e13617 Journal of Clinical Oncology 41, no. 16_suppl (June 01, 2023) e13617-e13617.
